PALOMAR MEDICAL TECHNOLOGIES INC
SC 13G, 1997-02-14
PRINTED CIRCUIT BOARDS
Previous: AMERICAN DISPOSAL SERVICES INC, SC 13G, 1997-02-14
Next: ABAXIS INC, 10-Q, 1997-02-14



<PAGE>   1


                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                -----------------

                                  SCHEDULE 13G

             INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO. )(1)




                The American Materials & Technologies Corporation
- --------------------------------------------------------------------------------
                                (Name of Issuer)



                     Common Stock, $0.01 par value per share
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)



                                   027397 10 8
                        ---------------------------------
                                 (CUSIP Number)



                                -----------------





                                ClK: 0000 8881695

                                  ccc: fjf9vii$





[FN]
- -------------------------

(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.

     The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).


<PAGE>   2



- -----------------------------                        ---------------------------
  CUSIP No. 027397 10 8                13G              Page  2  of  6  Pages
            -----------                                      ---    ---
- -----------------------------                        ---------------------------


- --------------------------------------------------------------------------------
   1      NAME OF REPORTING PERSONS
          S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

          Palomar Medical Technologies, Inc.
- --------------------------------------------------------------------------------
   2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP *   
                                                                   (a) [ ]
                                                                   (b) [ ]
- --------------------------------------------------------------------------------
   3      SEC USE ONLY


- --------------------------------------------------------------------------------
   4      CITIZENSHIP OR PLACE OF ORGANIZATION

          U.S.A.
- --------------------------------------------------------------------------------
                             5    SOLE VOTING POWER
                                                
                                  463,664
                           -----------------------------------------------------
      NUMBER OF              6    SHARED VOTING POWER
        SHARES   
     BENEFICIALLY                 0
       OWNED BY            -----------------------------------------------------
         EACH                7    SOLE DISPOSITIVE POWER                        
      REPORTING                       
     PERSON WITH                  463,604
                           -----------------------------------------------------
                             8    SHARED DISPOSITIVE POWER
                                  
                                  0
- --------------------------------------------------------------------------------
   9      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

          403,664
- --------------------------------------------------------------------------------
   10     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
          CERTAIN SHARES
                                                                   [ ]
- --------------------------------------------------------------------------------
   11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

          12.1
- --------------------------------------------------------------------------------
   12     TYPE OF REPORTING PERSON *

          CO
- --------------------------------------------------------------------------------


                     * SEE INSTRUCTIONS BEFORE FILLING OUT!



<PAGE>   3


- -----------------------------                        ---------------------------
  CUSIP No. 027397 10 8                13G              Page  3  of  6  Pages
            -----------                                      ---    ---
- -----------------------------                        ---------------------------



Item 1(a).    Name of Issuer:
              ---------------

              The American Materials & Technologies Corporation


Item 1(b).    Address of Issuer's Principal Executive Offices:
              ------------------------------------------------

              5915 Rodeo Road
              Los Angeles, CA 90016

Item 2(a).    Name of Persons Filing:
              -----------------------

              Palomar Medical Technologies, Inc.

Item 2(b).    Address of Principal Business Office or, If None, Residence:
              ------------------------------------------------------------

              66 Cherry Hill Drive
              Beverly, MA 01915

Item 2(c).    Citizenship:
              ------------

              U.S.A.

Item 2(d).    Title of Class of Securities:
              -----------------------------

              Common Stock, $0.01 par value per share

Item 2(e).    CUSIP Number:
              -------------

              027397 10 8

Item 3.       If this statement is filed pursuant to Rules 13d-1(b), or 
              ---------------------------------------------------------
              13d-2(b), check whether the person filing is a:
              -----------------------------------------------

              (a)  [ ] Broker or dealer registered under Section 15 of the Act;

              (b)  [ ] Bank as defined in Section 3(a)(6) of the Act;

              (c)  [ ] Insurance Company as defined in Section 3(a)(19) of the 
                       Act;

<PAGE>   4


- -----------------------------                        ---------------------------
  CUSIP No. 027397 10 8                13G              Page  4  of  6  Pages
            -----------                                      ---    ---
- -----------------------------                        ---------------------------



              (d)  [ ] Investment Company registered under Section 8 of the 
                       Investment Company Act;

              (e)  [ ] Investment Adviser registered under Section 203 of the 
                       Investment Advisers Act of 1940;

              (f)  [ ] Employee Benefit Plan, Pension Fund which is subject to 
                       the provisions of the Employee Retirement Income Security
                       Act of 1974 or Endowment Fund;

              (g)  [ ] Parent Holding Company, in accordance with Rule 13d-1(b)
                       (ii)(G);

              (h)  [ ] Group, in accordance with Rule 13d-1(b)(l)(ii)(H).

Item 4.       Ownership. (See Note A)
              -----------------------

              (a)   Amount beneficially owned:   463,664

              (b)   Percent of class:  12.1

              (c)   Number of shares as to which such person has:   463,664

              (i)   Sole power to vote or to direct the vote 463,664

              (ii)  Shared power to vote or to direct the vote    0

              (iii) Sole power to dispose or to direct the disposition of 
                    463,664

              (iv)  Shared power to dispose or to direct the disposition of   0



<PAGE>   5



- -----------------------------                        ---------------------------
  CUSIP No. 027397 10 8                13G              Page  5  of  6  Pages
            -----------                                      ---    ---
- -----------------------------                        ---------------------------


Item 5.       Ownership of Five Percent or Less of a Class.
              ---------------------------------------------

              N/A

Item 6.       Ownership of More than Five Percent on Behalf of Another Person.
              ----------------------------------------------------------------

              N/A


Item 7.       Identification and Classification of the Subsidiary Which Acquired
              ------------------------------------------------------------------
              the Security Being Reported on by the Parent Holding Company.
              -------------------------------------------------------------

              N/A

Item 8.       Identification and Classification of Members of the Group.
              ----------------------------------------------------------

              N/A

Item 9.       Notice of Dissolution of Group.
              -------------------------------

              N/A

Item 10.      Certification.
              --------------

              N/A


<PAGE>   6



- -----------------------------                        ---------------------------
  CUSIP No. 027397 10 8                13G              Page  5  of  6  Pages
            -----------                                      ---    ---
- -----------------------------                        ---------------------------



                                    SIGNATURE


     After reasonable inquiry and to the best of its knowledge and belief, the
undersigned certifies that the information set forth in this statement with
respect to it is true, complete and correct.



Date:  February 12, 1997




By: /s/ Steven Georgiev
   -------------------------------
   Chairman and Chief Executive Officer




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission